Alnylam Pharmaceuticals (ALNY) Accumulated Expenses (2009 - 2026)
Alnylam Pharmaceuticals' Accumulated Expenses was $1.1 billion in Q2 2026, up 19.3% from $918.97 million a year earlier and up 15.8% from the prior quarter.
Alnylam Pharmaceuticals (ALNY) Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Alnylam Pharmaceuticals came in at $1.08 billion, up 36.1% from FY2024.
- Accumulated Expenses has now increased for 13 consecutive years, with a five-year compound annual growth rate of 24.9% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $793.69 million in FY2024 (+11.3%), $713.01 million in FY2023 (+30.7%), $545.46 million in FY2022 (+38.0%) and $395.17 million in FY2021 (+11.0%).
- Quarterly Accumulated Expenses has moved between $355.94 million (Q1 2022) and $1.15 billion (Q3 2025) over five years.
- Compared with a year earlier, Accumulated Expenses has increased for 43 straight quarters, with growth averaging 21.3% over the last eight quarters.
- The year-over-year growth in Accumulated Expenses has ranged between 0.8% (Q1 2025) and 42.9% (Q1 2023) over the last five years.
- Per Business Quant data, ALNY's Accumulated Expenses in the three quarters before Q2 2026 was $946.49 million (Q1 2026), $1.08 billion (Q4 2025) and $1.15 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Bn |
| Mar 31, 2026 | 946.49 Mn |
| Dec 31, 2025 | 1.08 Bn |
| Sep 30, 2025 | 1.15 Bn |
| Jun 30, 2025 | 918.97 Mn |
| Mar 31, 2025 | 704.17 Mn |
| Dec 31, 2024 | 793.69 Mn |
| Sep 30, 2024 | 946.17 Mn |
| Jun 30, 2024 | 808.64 Mn |
| Mar 31, 2024 | 698.87 Mn |
| Dec 31, 2023 | 713.01 Mn |
| Sep 30, 2023 | 713.09 Mn |
| Jun 30, 2023 | 598.53 Mn |
| Mar 31, 2023 | 508.60 Mn |
| Dec 31, 2022 | 545.46 Mn |
| Sep 30, 2022 | 510.58 Mn |
| Jun 30, 2022 | 421.24 Mn |
| Mar 31, 2022 | 355.94 Mn |
| Dec 31, 2021 | 395.17 Mn |
| Sep 30, 2021 | 388.58 Mn |
Alnylam Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ALNY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();